CD8A and neoplasm: This metabolic reprogramming markedly improved mitochondrial function and survival of CD8+ T cells, enhanced tumor infiltration depth and cytotoxic activity of effector T cells, and ultimately elevated therapeutic response rates to ICIs (105).